Associate Professor Andrew Cox received his PhD from the University of Otago, New Zealand. He then undertook postdoctoral training at Harvard Medical School. In 2016, Dr Cox became a group leader at the Peter MacCallum Cancer Centre and holds a joint appointment in the Department of Biochemistry and Pharmacology at the University of Melbourne. His laboratory explores how metabolic reprogramming drives both adaptive tissue repair in liver regeneration and maladaptive responses in liver cancer initiation and progression. Dr Cox has received fellowships from the American Liver Foundation, the NHMRC, and the Victorian Cancer Agency.